Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 26, Number 3—March 2020

Research

Risk Factors for Complicated Lymphadenitis Caused by Nontuberculous Mycobacteria in Children

Martin Kuntz, Daniela S. Kohlfürst, Cornelia Feiterna-Sperling, Renate Krüger, Ulrich Baumann, Laura Buchtala, Roland Elling, Veit Grote, Johannes Hübner, Markus Hufnagel, Petra Kaiser-Labusch, Johannes Liese, Eva-Maria Otto, Markus A. Rose1, Christian Schneider, Volker Schuster, Maximilian Seidl, Olaf Sommerburg, Markus Vogel2, Horst von Bernuth, Michael Weiß, Theodor Zimmermann, Alexandra Nieters, Werner Zenz, Philipp HennekeComments to Author , and for the NTMkids Consortium
Author affiliations: University of Freiburg, Freiburg, Germany (M. Kuntz, R. Elling, M. Hufnagel, C. Schneider, M. Seidl, A. Nieters, P. Henneke); Medical University of Graz, Graz, Austria (D.S. Kohlfürst, W. Zenz); Charité–Universitätsmedizin Berlin, Berlin, Germany (C. Feiterna-Sperling, R. Krüger, H. von Bernuth); Hannover Medical School, Hannover, Germany (U. Baumann); Professor-Hess-Kinderklinik, Bremen, Germany (L. Buchtala, P. Kaiser-Labusch); Dr. von Hauner Children's Hospital, Munich, Germany (V. Grote, J. Hübner); University Children’s Hospital, Würzburg, Germany (J. Liese); Children’s Hospital, Cologne, Germany (E.-M. Otto, M. Weiß); Goethe University of Frankfurt, Frankfurt, Germany (M.A. Rose); University of Leipzig, Leipzig, Germany (V. Schuster); University of Heidelberg, Heidelberg, Germany (O. Sommerburg); Heinrich Heine University, Düsseldorf, Germany (M. Vogel); Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany (T. Zimmermann)

Main Article

Figure 2

Duration of nontuberculous mycobacteria lymphadenitis symptoms after patients’ first visit to a participating study center across 13 centers in Germany and Austria, 2010–2016. A represents combined data from the 10 smaller centers; B–D represent the 3 largest centers.

Figure 2. Duration of nontuberculous mycobacteria lymphadenitis symptoms after patients’ first visit to a participating study center across 13 centers in Germany and Austria, 2010–2016. A represents combined data from the 10 smaller centers; B–D represent the 3 largest centers.

Main Article

1Current affiliation: Olga Children’s Hospital, Stuttgart, Germany.

2Current affiliation: Hospital Neuwerk, Mönchengladbach, Germany.

Page created: February 20, 2020
Page updated: February 20, 2020
Page reviewed: February 20, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external